Recent advances in the pathogenesis and management of biliary atresia
- PMID: 25944310
- PMCID: PMC4447429
- DOI: 10.1097/MOP.0000000000000214
Recent advances in the pathogenesis and management of biliary atresia
Abstract
Purpose of review: The purpose of this study is to review advances in both the pathogenesis and clinical management of biliary atresia.
Recent findings: Immunologic studies have further characterized roles of helper T-cells, B-cells, and natural killer cells in the immune dysregulation following viral replication within and damage of biliary epithelium. Prominin-1-expressing portal fibroblasts may play an integral role in the biliary fibrosis associated with biliary atresia. A number of genetic polymorphisms have been characterized as leading to susceptibility for biliary atresia. Postoperative corticosteroid therapy is not associated with greater transplant-free survival. Newborn screening may improve outcomes of infants with biliary atresia and may also provide a long-term cost benefit.
Summary: Although recent advances have enhanced our understanding of pathogenesis and clinical management, biliary atresia remains a significant challenge requiring further investigation.
References
-
- Zhao D, Long XD, Xia Q. Recent Advances in Etiology of Biliary Atresia. Clinical pediatrics. 2014 - PubMed
-
- Hartley JL, Davenport M, Kelly DA. Biliary atresia. Lancet. 2009;374(9702):1704–1713. - PubMed
-
- Muraji T. Early detection of biliary atresia: past, present & future. Expert review of gastroenterology & hepatology. 2012;6(5):583–589. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
